Skip to content
Frequently Asked Question
Public Health

Antimicrobial resistance (AMR)

Last reviewed: August 8, 2026

Summary

Antibiotic use in food animals is widely recognized as a contributor to antimicrobial resistance, which threatens human health. Global analyses document large veterinary antimicrobial use, and health organizations recommend reducing non-therapeutic use.

Supported by 8 cited sources

Key Points

  • 1Antimicrobial exposure in food-producing animals selects for resistant bacteria, and resistant bacteria or resistance determinants can move among animals, humans, food, and environmental compartments (Marshall & Levy, 2011).
  • 2A systematic review and meta-analysis found that interventions restricting antibiotic use in food-producing animals were associated with a 10–15 percentage-point absolute reduction in resistance prevalence for many animal comparisons (Tang et al., 2017).
  • 3The evidence linking animal-use restrictions to resistance outcomes in directly exposed humans is supportive but smaller than the evidence in animals, and attribution for the general population remains less certain (Tang et al., 2017; Muloi et al., 2018).
  • 4The World Health Organization recommends ending routine use of medically important antibiotics for growth promotion and disease prevention in healthy animals (WHO, 2017).

Evidence Summary

Selection pressure and transmission pathways

Antibiotic exposure creates selection pressure: susceptible bacteria are suppressed while resistant organisms or resistance determinants can persist and spread (Marshall & Levy, 2011). Reviews of food-animal use describe elevated resistance in bacteria associated with animals receiving non-therapeutic antimicrobials and identify potential transmission through direct contact, the food chain, water, air, and manure- or sludge-amended soils (Marshall & Levy, 2011). These pathways differ by organism, drug class, production system, sanitation, occupational exposure, and local antimicrobial use (Marshall & Levy, 2011; Muloi et al., 2018).

Use is substantial at global scale (Tiseo et al., 2020). A modelling analysis using sales data from 41 countries estimated 93,309 tonnes of antimicrobials were sold for chickens, cattle, and pigs in 2017 and projected an 11.5% rise by 2030 under its assumptions (Tiseo et al., 2020). These are modelled sales estimates rather than direct measurements from every country, and reporting was more common among countries with larger export markets (Tiseo et al., 2020).

Evidence from reducing use

Intervention evidence most directly addresses resistance within animal populations after use restrictions (Tang et al., 2017). A systematic review identified 181 eligible studies; interventions restricting antibiotic use were commonly associated with absolute reductions of 10–15 percentage points in the prevalence of antibiotic resistance in animals, although results varied by antibiotic, bacterium, and specimen type (Tang et al., 2017). In the smaller set of human studies, pooled resistance prevalence was 24% lower in intervention groups, with a stronger association among people in direct contact with food-producing animals (Tang et al., 2017).

Evidence about direction of transmission is less definitive (Muloi et al., 2018). A systematic review focused on antimicrobial-resistant Escherichia coli found that studies often supported exchange between animal and human populations but that methodological limitations prevented robust conclusions about directionality in many settings (Muloi et al., 2018). Evidence that animal antibiotic use selects resistance is stronger than evidence assigning a precise fraction of human resistant infections to livestock in a particular place (Tang et al., 2017; Muloi et al., 2018).

Public-health recommendations

WHO recommends an overall reduction in medically important antibiotics in food-producing animals and complete restriction of their use for growth promotion and disease prevention without diagnosis (WHO, 2017). The same guidance retains therapeutic use for sick animals and recommends diagnosis, prudent drug selection, vaccination, hygiene, and changes in housing and husbandry as components of reduced routine use (WHO, 2017). Thus, reducing routine antibiotic use is a mainstream public-health priority, while implementation also requires disease-prevention measures that protect animal health (WHO, 2017).

The quantitative contribution of livestock use to human AMR varies by pathogen, resistance determinant, exposure route, geography, and surveillance method (Marshall & Levy, 2011; Muloi et al., 2018). Most intervention evidence concerns resistance in animals; only 21 of the 181 studies in Tang et al. reported human outcomes, so population-wide human effects are less certain (Tang et al., 2017). Global use estimates rely on incomplete sales reporting and modelling, particularly where national surveillance is limited (Tiseo et al., 2020). Reductions in routine use require accompanying vaccination, hygiene, housing, and husbandry changes rather than withholding indicated treatment from sick animals (WHO, 2017).

Supporting Evidence

The Bottom Line

Antibiotic use in food-producing animals contributes to selection and dissemination of antimicrobial resistance across connected animal, human, and environmental systems (Marshall & Levy, 2011). Restricting routine use reduces resistance in animal populations, with supportive but less extensive evidence for directly exposed humans (Tang et al., 2017). The size of the effect on the general human population remains setting-specific and harder to quantify (Muloi et al., 2018).

Practical Takeaways

For food-animal systems, the evidence supports avoiding medically important antibiotics for growth promotion or routine disease prevention in healthy animals while preserving veterinary treatment when clinically indicated (WHO, 2017). Vaccination, hygiene, diagnostic testing, and housing or husbandry changes are identified alternatives that can reduce reliance on routine antibiotics (WHO, 2017).

Sources & Evidence

8 sources cited across 7 claims

1

Livestock antibiotics contribute to AMR

Systematic Review
WHO, FAO, and OIE/WOAH One Health resources — World Health Organization; Food and Agriculture Organization of the United Nations; World Organisation for Animal Health (formerly OIE)View source ↗
2

WHO recommends reducing livestock antibiotics

Guideline
WHO, FAO, and OIE/WOAH One Health resources — World Health Organization; Food and Agriculture Organization of the United Nations; World Organisation for Animal Health (formerly OIE)View source ↗
3

Selection of resistance in food animals and transmission routes to humans and the...

Systematic Review
4

The effect of restricting antibiotic use on resistance in animals and the smaller...

Meta-Analysis
5

The scale and projected trend of antimicrobial sales for food animals, with reporting...

Observational
6

Uncertainty about the direction and magnitude of AMR transmission between food animals...

Systematic Review
7

WHO recommendations on routine antibiotic use and accompanying preventive husbandry...

Guideline

Disclaimer: This content is for informational purposes only and does not constitute medical or nutritional advice. Consult a qualified healthcare professional before making dietary changes.